Patents by Inventor Xueying Mao

Xueying Mao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Determining Prognosis of Cancer
    Publication number: 20230393138
    Abstract: The present invention provides a method for determining the prognosis of cancer in a subject. The method comprises measuring the amount of megakaryocytes in a sample from the subject. Usually, the sample is a blood sample. The method may also comprise measuring the number of circulating tumour cells (CTCs) in the sample, and in some embodiments a comparison of the number of megakaryocytes and CTCs in the sample. The present invention also provides methods of treatment for cancer in a patient for whom a poor prognosis is predicted using a method of prognosis of the invention.
    Type: Application
    Filed: August 4, 2023
    Publication date: December 7, 2023
    Inventors: Tianyu Guo, Lei Xu, Xueying Mao, Yong-Jie Lu
  • Method for Determining Prognosis of Cancer
    Publication number: 20230110513
    Abstract: The present invention provides a method for determining the prognosis of cancer in a subject. The method comprises measuring the amount of megakaryocytes in a sample from the subject. Usually, the sample is a blood sample. The method may also comprise measuring the number of circulating tumour cells (CTCs) in the sample, and in some embodiments a comparison of the number of megakaryocytes and CTCs in the sample. The present invention also provides methods of treatment for cancer in a patient for whom a poor prognosis is predicted using a method of prognosis of the invention.
    Type: Application
    Filed: December 14, 2022
    Publication date: April 13, 2023
    Inventors: Tianyu Guo, Lei Xu, Xueying Mao, Yong-Jie Lu
  • Method for Determining Prognosis of Cancer
    Publication number: 20190277852
    Abstract: The present invention provides a method for determining the prognosis of cancer in a subject. The method comprises measuring the amount of megakaryocytes in a sample from the subject. Usually, the sample is a blood sample. The method may also comprise measuring the number of circulating tumour cells (CTCs) in the sample, and in some embodiments a comparison of the number of megakaryocytes and CTCs in the sample. The present invention also provides methods of treatment for cancer in a patient for whom a poor prognosis is predicted using a method of prognosis of the invention.
    Type: Application
    Filed: October 19, 2017
    Publication date: September 12, 2019
    Inventors: Tianyu Guo, Lei Xu, Xueying Mao, Yong-Jie Lu